Abbott Laboratories, Reckitt and baby formula

Abbott, Reckitt face new trial over premature infant formula
A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialized baby formulas for premature infants,
In a setback for Abbott Laboratories, judge allows new trial in case over formula for premature infants
The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.
That baby formula trial Abbott and Reckitt had won isn't over just yet
Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a baby developing necrotizing enterocolitis, or NEC, from their cow-milk-based formulas. NEC is a serious, and sometimes deadly, gastrointestinal disease that primarily afflicts premature infants.
Reckitt says US court grants new trial in premature-infant formula case
Reckitt said on Friday a U.S. circuit court has ruled that a new trial could be sought by plaintiffs in a case that had accused the London-listed firm and Abbott of failing to warn of the risks of premature baby formulas.
Pharma giants face new trial over infant formula
MISSOURI: A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialised baby formulas for premature infants, re-opening a case that had resulted in a victory for the defendants.
Reckitt Shares Drop on Infant Formula Retrial in U.S.
Reckitt--which houses Dettol, Harpic and Durex among its brands--said the judge ordered a retrial of a Missouri lawsuit that had found in October that subsidiary Mead Johnson wasn't liable for injuries suffered by a child who consumed its formula designed for premature babies.
Abbott, Reckitt Fall as Judge Grants New Trial on Infant Formula
Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they hid potential risks of their premature-infant formulas.
Abbott Labs and Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case
Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their favor.
Only two drops of blood needed: New test unveils the immune landscape of preterm babies
Preterm babies are fragile. This is especially true for infants born just six to seven months into a pregnancy. Called ...
He Fought Claims of Harm From Infant Formula. Now He Regulates It.
Kyle Diamantas, a former corporate lawyer, is the new director for the F.D.A. food division, which oversees infant formula.
News Medical on MSN9d
Feeding strategies in preterm infants do not alter brain growth or cognition
Early nutrition in very preterm infants does not significantly impact brain growth or neurodevelopment when following ...
MassDevice4d
First patient enrolled in Merit Medical occluder system study
Merit Medical Systems announced today that investigators enrolled the first patient in a study of its Bloom micro occluder ...